A Phase II, Randomized, Placebo-controlled Trial of the Safety, Efficacy, Pharmacodynamics and Pharmacokinetics of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 20 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Sep 2016 According to Pharnext media release,data from this trial will be presented at the 6th international Charcot-Marie-Tooth and Related neuropathy Consortium (CMTR) conference.
30 Jun 2015 Baseline analysis presented at the 2015 Peripheral Nerve Society (PNS) Biennial Meeting, according to a Pharnext media release.
17 Dec 2014 According to a Pharnext Media Release, results were published in Orphanet Journal of Rare Diseases journal.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com